These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7108628)

  • 1. [75Se]Selenomethylcholesterol uptake in familial congenital Cushing's.
    Shapiro B; Grant DB; Britton KE
    J Nucl Med; 1982 Sep; 23(9):799-800. PubMed ID: 7108628
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with 75Se selenomethylcholesterol adrenal imaging.
    Shapiro B; Britton KE; Hawkins LA; Edwards CR
    Clin Endocrinol (Oxf); 1981 Jul; 15(1):19-27. PubMed ID: 7307282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal scintigraphy with 75Se selenonorcholestenol: a review.
    Sudell CJ; Blake GM; Gossage AA; Cullen DR; Munro DS
    Nucl Med Commun; 1985 Sep; 6(9):519-27. PubMed ID: 4069475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium-75-cholesterol imaging and computed tomography of the adrenal glands in differentiating the cause of Cushing's syndrome.
    Miller JL; Smith JA; Mervis B; Roman T
    S Afr Med J; 1983 May; 63(22):848-50. PubMed ID: 6857400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
    Reschini E; Catania A
    Eur J Nucl Med; 1991; 18(10):817-23. PubMed ID: 1743205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiocholesterol scintigraphy in Cushing's syndrome.
    Rufini V; Saletnich I; Troncone L
    Rays; 1992; 17(1):40-8. PubMed ID: 1636017
    [No Abstract]   [Full Text] [Related]  

  • 7. Selenium 75 selenomethyl cholesterol: a new agent for quantitative functional scintigraphy of the adrenals: physical aspects.
    Hawkins LA; Britton KE; Shapiro B
    Br J Radiol; 1980 Sep; 53(633):883-9. PubMed ID: 7437711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of 6-methyl-75Se-selenomethyl-19-nor-cholest-5(10)-en-3 beta-ol (Scintadren) (author's transl)].
    Takahashi T; Yamazaki M; Haruyama K; Fukuch S; Kida T
    Kaku Igaku; 1980 Mar; 17(2):211-7. PubMed ID: 7382186
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake of 75Se-selenomethylcholesterol by a nonfunctioning adrenocortical adenoma.
    Reschini E; Catania A; Silva A; Cantalamessa L
    J Nucl Med Allied Sci; 1984; 28(3):221-4. PubMed ID: 6530626
    [No Abstract]   [Full Text] [Related]  

  • 10. The diagnosis of Cushing's syndrome using 131I-19-iodocholesterol uptake and adrenal imaging.
    Ortega D; Foz M; Doménech-Torné FM; Tresánchez JM
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):145-9. PubMed ID: 7438469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG uptake in bilateral adrenal hyperplasia causing Cushing's syndrome.
    Basu S; Nair N
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):384. PubMed ID: 15791448
    [No Abstract]   [Full Text] [Related]  

  • 12. [75Se -- selenocholesterol -- a new radionuclide for adrenal scintiscanning. Preliminary clinical investigations (author's transl)].
    Jakubowski W; Mariss P
    Pol Przegl Radiol Med Nukl; 1980; 44(3):223-5. PubMed ID: 7001396
    [No Abstract]   [Full Text] [Related]  

  • 13. [Scintigraphic investigations of the adrenals by means of 75Se-selenocholesterol (author's transl)].
    Jakubowski W; Feltynowski T; Graban W
    Pol Przegl Radiol Med Nukl; 1980; 44(4):307-10. PubMed ID: 7243634
    [No Abstract]   [Full Text] [Related]  

  • 14. Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist?
    Charbonnel B; Chatal JF; Ozanne P
    J Nucl Med; 1981 Dec; 22(12):1059-61. PubMed ID: 6273512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of 75Se-selenocholesterol by an adrenal cortical carcinoma and its metastases.
    Reschini E; Peracchi M
    Eur J Nucl Med; 1984; 9(6):291-3. PubMed ID: 6745299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the scintigram in the diagnosis of adrenal diseases].
    Nakajo M
    Rinsho Hoshasen; 1986 Apr; 31(4):495-8. PubMed ID: 3735709
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial Cushing's syndrome. Micronodular adrenocortical dysplasia.
    Hodge BO; Froesch TA
    Arch Intern Med; 1988 May; 148(5):1133-6. PubMed ID: 3365080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
    Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
    J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [131I-19-iodocholesterol adrenal scanning in Cushing's syndrome (author's transl)(proceedings)].
    Charbonnel B; Chatal JF; Chupin M; Guillon J
    Ann Endocrinol (Paris); 1976; 37(4):315-6. PubMed ID: 192129
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members.
    Nies C; Bartsch DK; Ehlenz K; Wild A; Langer P; Fleischhacker S; Rothmund M
    Exp Clin Endocrinol Diabetes; 2002 Sep; 110(6):277-83. PubMed ID: 12373631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.